Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine fumarate injection for ICU mechanical ventilation analgesia
CTR20260026Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegileridine in pain, sponsored by Hengrui Therapeutics. Started Feb 2026; status: completed.
02
Drugs
tegileridine
03
Conditions
pain
Beyond the preview
Go deeper on CTR20260026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260026.